CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

HONG KONG: China's CanSino Biologics Inc said on Sunday (Sep 4) that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. The inhaled version of CanSino's adenovirus-vectored COVID-19 vaccine has obtai

HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

"The approval will have a positive impact on the company's performance if the vaccine is subsequently purchased and used by relevant government agencies," CanSino said. CanSino also said it was uncertain when its vaccine would be able to go to market, since additional administrative approvals are still needed, while sales would depend on the COVID-19 situation at home and abroad, as well as China's vaccination rate.Shenzhen imposed a weekend lockdown

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

DrAndyTsun Is it based on traditional inactivated virus?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tiny discovery in Chinese lab could be a big deal in stopping Covid-19A Chinese research team has developed a nanomaterial that can find Sars-CoV-2 viruses in a living cell and remove them. Unlike most existing Covid-19 drugs, the material can inhibit infections from all major variants including Alpha, Beta, Delta and Omicron with high biosafety, the researchers said. “It can be a promising therapy to fight the pandemic in the future,” said...
Source: asiaonecom - 🏆 10. / 59 Read more »

China's Shenzhen extends Covid-19 curbs but stops short of full lockdownSHENZHEN, China – Some districts of China's southern tech hub Shenzhen extended curbs on public activities, dining out and entertainment venues on Friday (Sept 2), but city officials stopped short of a full lockdown as they try to rein in rising Covid-19 cases. Restrictions in the central business district of Futian and Longhua, home to a major campus of Apple...
Source: asiaonecom - 🏆 10. / 59 Read more »

China approves Livzon Pharma's COVID-19 vaccine, among first new products in more than a yearBEIJING: China granted emergency use authorisation to Livzon Pharmaceutical Group's COVID-19 vaccine as a booster, the firm said on Friday (Sep 2), marking one of the two new products against the disease the country cleared in more than a year. Livzon's vaccine, if rolled out to the public, would widen boo
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

'Completely new' COVID-19 strains possible this winter: European UnionTHE HAGUE: Entirely new COVID-19 variants could emerge this winter but existing vaccines should protect people from serious illness and death, the European Union's drug agency said on Friday (Sep 2). The comments came as the 27-nation EU prepares to Also EU:
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

'Completely new' Covid-19 strains possible this winter: EUExisting vaccines should protect people from serious illness and death, the EU's drug agency said on Friday (Aug 2). Read more at straitstimes.com.
Source: STForeignDesk - 🏆 4. / 71 Read more »